The cervical cancer vaccine, Cervavac, is a Quadrivalent Human Papillomavirus vaccine (qHPV)developed by the Serum Institute of India (SII) and the Department of Biotechnology (DBT).
The list for 2022 featured 11 start-up companies from India along with 19 companies from Singapore, followed by 16 start-ups from Hong Kong, 15 from South Korea, and 13 from China.
The Ministry of Women and Child Development will celebrate the 5th Rashtriya Poshan Maah 2022 from 1st to 30th Sept 2022 as part of the POSHAN Abhiyaan.
EXAMIANS